Investigational Drug Combined With Chemotherapy Improves Response in Patients With BRCA -Mutant Breast Cancer

Cancer - United States
doi 10.1002/cncr.30610
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

BRCAness Combined With Family History of Cancer Is Associated With Poor Prognosis in Breast Cancer Patients With High Risk of BRCA Mutations

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Imaging Breast Cancer Chemotherapy Response With Light

Clinical Cancer Research
Cancer ResearchOncology
2010English

BRCA Mutations in Women With Inflammatory Breast Cancer

Cancer
Cancer ResearchOncology
2017English

The Value of BRCA 1 Gene Mutation in Patients With Breast Cancer

Sohag Medical Journal
2018English

Response to Chemotherapy and Association With Three Tumour Markers in Breast Cancer Patients in Ghana

International Journal of Cancer Therapy and Oncology
2014English

Correlation of Post-Neoadjuvant Chemotherapy Response on MRI With Final Histology in Breast Cancer Patients

Breast Cancer Research
Cancer ResearchOncology
2015English

Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2010English

MRP1 but Not MDR1 Is Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2013English

Epigenetic Changes Associated With Inflammation in Breast Cancer Patients Treated With Chemotherapy

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy